Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P160030/S058

Freestyle Libre Flash Glucose Monitoring System

Abbott Diabetes Care, Inc. · Decision date Sep 1, 2026

MEDTECHLEDGER EXPLANATIONP160030/S058

What did the FDA decide?

P160030/S058 is a 30-day notice recorded with decision OK30 on 2026-09-01 for the FreeStyle Libre Flash Glucose Monitoring System. The reported change is the addition of a secondary supplier and manufacturer for subcomponents and subassemblies for sensor kits. The sensor is a component of the FreeStyle Libre 14-day and FreeStyle Libre Pro systems; the source gives no further detail on which subcomponents, which supplier, or which manufacturing steps are involved.

Because the identifier and supplement type establish it, this is a supplement to PMA P160030, not an original approval of the whole system, and it does not alter the parent approval. The field label categorizes the reason as a process change involving a manufacturer, sterilizer, packager or supplier. The stated purpose is administrative and manufacturing-related; it is not independent evidence of sensor safety or clinical effectiveness, and no new indication or clinical use should be inferred.

FDA approval order statement

addition of a secondary supplier and manufacturer for subcomponents and subassemblies for sensor kits. The sensor is a component of the FreeStyle Libre 14-day and FreeStyle Libre Pro Flash Glucose Monitoring Systems
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Clinical Chemistry
Decision date
Sep 1, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P160030/S058
Regulatory pathway
PMA supplement
Product code
PZE
Decision code
OK30
Decision date
Sep 1, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Sensor, glucose, invasive, non-adjunctive, factory-calibrated, user-initiated.

Product code
PZE
FDA device class
3

For the original device and its historical approval scope, see PMA P160030. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P160030 · Original PMA

    Freestyle Libre Flash Glucose Monitoring System

  2. P160030/S058 received

    Application receipt date recorded by FDA.

  3. P160030/S058 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P160030. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P160030

Product / regulatory recordCompanyPathwayDecision dateSource
Abbott Diabetes Care, Inc.PMA approvalSep 27, 2017FDA

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Diabetes Care, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
1360 S. Loop Dr., Alameda, CA, 94502

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records